Preventing muscle relaxant anaphylaxis with monovalent haptens. A preliminary study.
Moneret-Vautrin
D A
DA
Service de Médecine D, CHU de Brabois, Vandoeuvre-lès-Nancy.
Motin
J
J
Mata
E
E
Guéant
J L
JL
Kanny
G
G
Widmer
S
S
Laxenaire
M C
MC
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced / Q000517:prevention & control*; D004979:Ethamsylate / Q000008:administration & dosage; D005260:Female; D006241:Haptens / Q000008:administration & dosage*; D006636:Histamine Release; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*; D011863:Radioimmunoassay; D012882:Skin Tests
D006241:Haptens; D009025:Morpholines; D009466:Neuromuscular Blocking Agents; D004979:Ethamsylate; C003602:tiemonium iodide